Document Detail


Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
MedLine Citation:
PMID:  11009288     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Based on epidemiologic facts on elevated cardiovascular mortality in renal allograft recipients, an echocardiographic 2-year follow-up in hypertensive renal allograft recipients was conducted. This study provides evidence that, in contrast to atenolol, quinapril, independent of blood pressure reduction, reduces left ventricular hypertrophy and improves left ventricular diastolic function in this population.
Authors:
B Suwelack; U Gerhardt; M Hausberg; K H Rahn; H Hohage
Related Documents :
2945668 - Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the a...
14570598 - Effects of renal artery stenting on renal function and blood pressure in patients with ...
11886768 - Resistive index of renal artery and blood pressure in postmenopausal women.
961848 - Isohemic blood volume expansion in normal and areflexive dogs.
17011368 - Changes in heart rate with refeeding in anorexia nervosa: a pilot study.
23330658 - Comparative effect of candesartan and amlodipine, and effect of switching from valsarta...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  86     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-10-05     Completed Date:  2000-10-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  583-5, A10     Citation Subset:  AIM; IM    
Affiliation:
Medical Department D, University of Münster, Germany. suwelac@uni-muenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*,  therapeutic use
Angiotensin-Converting Enzyme Inhibitors / pharmacology*,  therapeutic use
Antihypertensive Agents / pharmacology,  therapeutic use
Atenolol / pharmacology*,  therapeutic use
Blood Pressure / drug effects*
Diastole / drug effects
Double-Blind Method
Heart Ventricles / anatomy & histology,  drug effects
Humans
Hypertension / drug therapy,  physiopathology*
Hypertrophy, Left Ventricular / drug therapy*
Isoquinolines / pharmacology*,  therapeutic use
Kidney Transplantation / physiology*
Middle Aged
Tetrahydroisoquinolines*
Ventricular Function
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Isoquinolines; 0/Tetrahydroisoquinolines; 29122-68-7/Atenolol; 82586-55-8/quinapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Holter monitoring: are two days better than one?
Next Document:  Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction i...